. The rank order of the five most common cancers affecting Jordanians are: Breast, Colorectal, Lymphoma, Lung, and Prostate. The crude incidence rate of all cancer among Jordanians was 79.4 per 100,000 population (74.0 for males and 85.1S for females). The lung cancer agestandardized rate (ASR) for incidence/mortality in men (27.0/24.1) is substantially higher than women (4.1/3.7) (Ferlay et al., 2012) .
Introduction
Lung cancer (LC) is the most common cancer in the world with an estimated 1.8 million new cases in 2012. It is also the most common cause of death from cancer, with 1.59 million deaths. Incidence depends on gender and ethnicity. LC is the most frequent cancer in men and the fourth in women. The majority of the cases are in the developing countries (55%) and the lowest rates are estimated in Middle and Western Africa. Patients with LC suffer from high fatality with the ratio of mortality to incidence is 0.87 irrespective of geographical location ranging from 0.75 (USA) to 0.94 (Africa) (Ferlay et al., 2012) .
In Jordan, cancer is the second most frequent cause Folate metabolism is thought to play a critical role in carcinogenesis through its involvement in DNA methylation and repair. Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in folate metabolism (Cicek et al., 2004; Lucock, 2004) . It converts 5,10-methylenetetrahydrofolate irreversibly to 5-methyltetrahydrofolate (5-MeTHF) which in turn donates its methyl group to homocysteine in the generation of S-adenosylmethionine (SAM). SAM is a major source of methyl groups used for DNA methylation. MTHFR maintains circulating levels of 5-MeTHF and methionine, and prevents the accumulation of homocysteine (Lucock, 2004) .
A number of molecular epidemiological studies have been conducted to investigate the associations of the MTHFR C677T and A1298C polymorphisms with lung cancer predisposition. However, the results remain conflicting rather than conclusive (Mao et al., 2008; Boccia et al., 2009; Zhang et al., 2012) .
Genetic polymorphism in MTHFR may be related to the risk for lung cancer, but this may not hold true for all populations (Mao et al., 2008; Boccia et al., 2009; Zhang et al., 2012) . The aim of this study was to determine if MTHFR C677T and A1298C polymorphism is/are associated with an altered risk of developing lung cancer among Jordanians.
Materials and Methods

Study design and population
In this case-control study, paraffin-embedded tissues from histologically confirmed lung cancer cases from (98) unrelated Jordanian patients previously diagnosed with lung cancer were collected from Jordan University Hospital (JUH). Histologically, 88 cases were non-smallcell carcinoma mainly squamous cell carcinoma (N=35) and adenocarcinoma (N=30). The remaining 10 cases were small-cell carcinoma.
The control group consisted of (89) healthy individuals from the same geographical area as the lung cancer patients who consented to analysis of their biological samples. The study protocol was approved by the Institutional Review Board (IRB) at JUH. The study was exempted by the IRB from obtaining a formal written consent from patients for paraffin-embedded samples.
Not all samples were successfully analyzed for the two SNPs due to sample depletion, failure of PCR or failure of endonuclease digestion. Four cases had data at 1298 but not at 677, and three cases had data at 677 but not at 1298. One control had data at 1298 but not at 677, and two controls had data at 677 but not at 1298.
MTHFR genotyping
DNA from paraffin-embedded blocks of patient and control samples was extracted using an FFPE kit (Qiagen, Germany) according to the manufacturer's instructions. Genotyping was performed for both polymorphisms, C677T and A1298C, by two separate polymerase chain reaction (PCR) reactions using a thermal cycler (model PTC-100; Bio-Rad-MJ Research, Watertown, MA). Amplification of the C677T region was performed using the forward primer TGAAGGAGAAGGTGTCTGCGGGA (NT_021937.19: 7,861,134 to 7,861,112) and the reverse primer AGGACGGTGCGGTGAGAGTG (NT_021937.19: 7,860,937 to 7,860,956 ) yielding a 198-bp band, whereas for the A1298C region, the forward primer CAAGGAGGAGCTGCTGAAGA (NT_021937.19: 7,859,255 to 7,859,236) , and the reverse primer CCACTCCAGCATCACTCACT (NT_021937.19: 7,859,128 to 7,859,147) , were used yielding a 128-bp band. For both amplifications, the PCR conditions were described by Yi et al. (2002) Findings of the PCR-RFLP were validated by: 1) inclusion of a negative control in all PCR analyses; negative controls contain all PCR components except DNA template; 2) repeat analysis of approximately 15% of all samples; concordance between repeated samples was 100%; and 3) direct DNA sequencing of 30 randomly selected PCR-RFLP digests using BigDye Terminator Cycle Sequencing on 3730xl DNA sequencer (Macrogene ® Co., Korea).
Haplotype analysis
The interaction between genetic polymorphism at the two loci was assessed by evaluating the combinedgenotype effects by haplotype analysis. We analyzed the haplotype frequencies of the two SNPs for lung cancer cases and compared them with those of controls. Haplotype frequencies were calculated using Golden Helix Tree ® software and linkage disequilibrium was represented by D prime (D'). The Golden Helix software is enabled to estimate the haplotype frequencies even with presence of some missing data of one or two of the SNPs. Similar findings were obtained utilizing Multiallelic Interallelic Disequilibrium Analysis Software (University of Southampton, Highfield, Southampton, UK)
Statistical analysis
Statistical analysis was performed using SPSS © software (version 11.0; SPSS, Inc, Chicago, IL 
Results
Demographics
A total of 98 lung cancer patients and 89 control subjects were included in this study. The patients comprised 78 males and 20 females (M/F ratio = 3.9) and the control subjects consisted of 46 males and 43 females (M/F ratio=1.1). Significant gender differences were observed between the groups (p< 0.001). Lung cancer cases were 2.5 years older than controls (p=0.16). More than half of the recruited sample was smokers (99; 52.9%). Smoking was more likely in lung cancer patients than controls ( LC: 77; (78.6%) vs Controls: 22 (24.7%); OR: 11.2 (95%CI: 5.6-22.1); p<0.001). Men were more likely to smoke than women (men: 89 ( 
Genetics
The distribution of MTHFR C677T and A1298C genotypes and their alleles are presented in Table 1 . Neither C677T genotypes nor alleles was statistically different in lung cancer cases and controls (table 1) . However, there were statistically significant differences in the genotype frequency of MTHFR A1298C between LC cases and the controls. The frequency of the MTHFR C allele was higher in patients with LC compared with healthy controls (Table 1 ). The CC genotype was associated with a 2.3 to 2.5-fold higher risk of LC (p=0.031); the AC genotype was associated with a 1.1-fold higher risk, albeit not statistically significant (p=0.74). Subjects with the C allele were 1.5 time more likely to suffer from lung cancer (p=0.057).
The allelic distribution of the two SNPs was in Hardy Weinberg equilibrium [(C677T: LC (X 2 : 0.84, p=0.4); controls: (X 2 :0.22, p=0.6)), (A1298C: LC (X 2 : 0.82, p=0.4); controls: (X 2 :0.48, p=0.5))]. 
Genetics and smoking
The interaction between genotype and smoking was assessed for the two SNPs. There was no statistically significant difference between C677T genotypes and smoking (smokers: 54CC, 35CT, 7TT; non-smokers: 45CC, 31CT, 9TT, p=0.73) and between A1298C genotypes and smoking (smokers: 31AA, 47AC, 19CC; non-smokers: 29AA, 40AC, 16CC, p=0.95).
Stratification of data based on sample type (controls or LC) yielded no significant differences when comparing C677T genotypes to smoking [Lung cancer: (smokers: 42CC, 27CT, 5TT; non-smokers: 14CC, 4CT, 2TT, p=0.37); (Control: (smokers: 12CC, 8CT, 2TT; nonsmokers: 31CC, 27CT, 7TT, p=0.86)]. Similar findings We analyzed genotype data for the two tissue types once among smokers and then among non-smokers. The 677 genotypes of MTHFR were distributed similarly between smokers of either tissue type (LC-smokers: 42 CC, 27 CT, 5 TT vs controls-smokers: 12 CC, 8 CT, 2 TT, p= 0.9). Similar findings were observed among the non-smokers.
There were statistically significant differences in 1298 genotypes of MTHFR among smokers (LC-smokers: 20 AA, 37 AC, 18 CC vs controls-smokers: 11 AA, 10 AC, 1 CC, p= 0.044). There was no statistically significant difference in any of 1298 genotypes of MTHFR among non-smokers. 1298CC genotype of MTHFR presented 9.9 times higher risk of LC in smokers as compared with the AA carriers (Table 2) .
Genetics and gender
There was no statistically significant difference between C677T genotypes and gender distribution (Men: 60CC, 49CT, 10TT; Women: 39CC, 17CT, 6TT, p=0.19). Similarly, stratification of data based on sample type (controls or LC) yielded no significant differences when comparing C677T genotypes to gender [(Controls: Men: 20CC, 21CT, 4TT; Women: 23CC, 14CT, 5TT, p=0.43); (Lung cancer: Men: 40CC, 28CT, 6TT; Women: 16CC, 3CT, 1TT, p=0.11)]. We analyzed genotype data for the two tissue types once among men and then among women. There was no statistically significant difference in any of 677 genotypes of MTHFR among men (controls-men: 20 CC, 21 CT, 4 TT vs LC-men: 40 CC, 28 CT, 6 TT, p=0.6). Similar findings were observed among women (controls-women: 23 CC, 14 CT, 5 TT vs LC-women: 16 CC, 3 CT, 1 TT, p=0.2).
There was no statistically significant difference between A1298C genotypes and gender distribution (Men: 39AA, 61AC, 22CC; Women: 21AA, 26AC, 13CC, p=0.68). Similarly, stratification of data based on sample type (controls or LC) yielded no significant differences when comparing A1298C genotypes to gender [(Controls: Men: 20AA, 23AC, 3CC; Women: 12AA, 21AC, 8CC, p=0.13); (Lung cancer: Men: 19AA, 38AC, 19CC; Women: 9AA, 51AC, 5CC, p=0.11)]. We analyzed genotype data for the two tissue types once among men and then among women. There were statistically significant differences in 1298 genotypes of MTHFR among men (controls-men: 20 AA, 23 AC, 3 CC vs LC-men: 19 AA, 38 AC, 19 CC, p=0.014). There was no statistically significant difference in any of 1298 genotypes of MTHFR among women. Carriers of the 1298CC genotype were 6.7 times higher risk of LC in men as compared with the AA carriers (Table 2) .
Genetics, smoking and gender
We analyzed 677 genotypes among "men who were smokers" in the two tissue categories. Different genotypes were distributed similarly between LC and controls (LC: CC= 37, CT= 26, TT= 4 vs Controls: CC= 9, CT= 8, TT= 2; p=0.7).
We analyzed 1298 genotypes among "men who were smokers" in the two tissue categories. The genotypes were distributed differently (LC: AA= 18, AC= 35, CC = 16 vs Controls: AA= 10, AC= 9, CC = 0, p= 0.02). Carriers of 
Logistic regression
Backward stepwise logistic regression with conditional likelihood was used to find out the best subset of variables to predict lung cancer. The logistic regression was specified for significance level of 0.05 for entry and at level of 0.1 for removal. The different models were compared by conditional logistic regression. The Wald statistic was used in comparing the fitness of combined models. As a further check, -2 log-likelihood ratio statistic was utilized. Only when the two statistics agree, then the predictor is decided to be useful for the model. The following variables were evaluated as predictors of lung cancer: gender; smoking; age; and A1298C genotypes (CC vs others). The HosmerLemeshow statistic indicated that the model adequately fits the data (p=0.685). The Nagelkerke's R 2 of the prediction model was 0.383. As a further check, the model was built using forward stepwise methods. The two methods chose the same variables. Smoking behavior and the 12988CC genotype remained statically significant with adjusted odds ratio of 12.1 (95% CI: 6.0-25; p<0.001) and 3.2 (95% CI: 1.3-8.2; p=0.015), respectively.
The logistic regression was repeated again utilizing A1298C genotypes CC vs AA rather than CC vs others. The other predictors were retained (gender; smoking, age). The Hosmer-Lemeshow statistic was (p=0.223) and the Nagelkerke's R 2 was (0.36). Smoking behavior and the 12988CC genotype remained statically significant with adjusted odds ratio of 8.1 (95% CI: 3.1-22.7; p<0.001) and 3.5 (95% CI: 1.2-10.1; p=0.02), respectively.
MTHFR haplotypes
All four different haplotypes appeared in our analysis. The most frequent haplotypes were CA (677C-1298A) (LC: 33.1%; controls: 36.9%), and CC (LC: 43.9%; controls: 33.4%) followed by TA (LC: 21.3%; controls: 24.7%), while the rare haplotype was TC (LC: 1.7%; controls: 5%) ( : 0.08). Carriers of the CC haplotype were 1.6-fold more likely to be associated with lung cancer (OR: 1.6; 95% CI: 1.03-2.4, p=0.037). None of the remaining haplotypes was associated with LC.
Discussion
The mechanism of lung carcinogenesis is, like other cancers, still not fully understood. Among the lifestyle related causes of lung cancer, smoking is the primary risk factor for lung cancer. However, lung cancer develops in less than 20% of people who smoke throughout their life (Shields, 2002) This suggests that other factors including genetic susceptibility and nutritional habits contribute to carcinogenesis of lung cancer (Perera, 1998) . Examination of genetic polymorphisms may explain individual differences in cancer risk.
Folate metabolism is thought to play a critical role in carcinogenesis through its involvement in both DNA methylation and repair. Previous studies revealed higher risk of breast and esophagus cancer but not colorectal cancer with less functional forms of MTHFR (Ergul et al., 2003; Stolzenberg-Solomon et al., 2003; Pardini et al., 2011) . The MTHFR gene is located at the end of the short arm of chromosome 1 (1p36.3) (Goyette et al., 1998) . The two common functional polymorphisms have been defined in the MTHFR gene -one is C677T (rs1801133; NT_021937.19: 7,861,110) and another is A1298C (rs1801131; NT_021937.19: 7,859,208) .
MTHFR C677T polymorphism results in substitution of alanine by valine at amino acid 222 in exon 4 (Frosst et al., 1995; Sharp and Little, 2004) . Studies indicated that subjects with the TT or CT genotype have lower levels of enzyme activity, 30% and 65%, respectively, relative to enzyme activity in subjects carrying the CC genotype (Frosst et al., 1995; Kono and Chen, 2005; Brockton, 2006) . Additionally, this single nucleotide polymorphism (SNP) decreases the thermal stability of this enzyme (Cicek et al., 2004) . It has been reported that this substitution may lower levels of 5-methyltetrahydrofolate, and increase plasma homocysteine levels (Frosst et al., 1995; Ma et al., 1997; Bagley and Selhub, 1998) .
Generally speaking, the number of studies that evaluated the relationship between MTHFR genetic polymorphism and LC risk is few and moreover their findings have been conflicting where some yielded an increased risk (Siemianowicz et al., 2003; Shen et al., 2005; Hung et al., 2007; Vineis et al., 2007; Arslan et al., 2011) , a decreased risk (Jeng et al., 2003; Shi et al., 2003; Suzuki et al., 2007; Liu et al., 2009; Cui et al., 2011) or no association (Shen et al., 2001; Heijmans et al., 2003; Liu et al., 2008; Truong et al., 2010) .
Prior to our investigation, based on Zhang et al, the studies that investigated MTHFR C677T and A1298C were distributed by ethnicity as follows: 5 studies recruited Caucasians (USA, The Netherlands, Poland and France); 9 studies examined individuals of Asian descent (China, Taiwan, Korea, and Japan); the last study was from Turkey (Zhang et al., 2012) . This is the first study conducted in Jordan and the in the Arab world. Jordanians are mostly descended from people of villagers and Bedouin descent originating in the Arabian Peninsula (Lowi, 1995) ; thus, ethnically, the Jordanians represent a mixed stock. Most of the population is Arab (approximately 98%) with 1% of the population, Armenian, and another 1%, Circassian. There are also Kurd, Druze, and Chechen minorities (Central Intelligence Agency, 2012; The Royal Hashemite Court, 2012). In 2008, Mao et al. performed a meta-analysis based on eight studies and did not find a relationship between the MTHFR polymorphisms and the risk of lung cancer (Mao et al., 2008) . In 2009, another meta-analysis aggregated with ten studies and also did not find a significant relationship between the polymorphisms and lung cancer risk, but an increased risk for individuals with low folate intake (Boccia et al., 2009) . In 2012, a meta-analysis of 14 publications found no significant association between the MTHFR C677T polymorphism and LC risk irrespective of race, Stratified analysis by histological type indicated significantly increased nonsmall-cell lung cancer (NSCLC) risk among the T allele carriers (T-allele vs C-allele: OR=1.11, 95%CI=1.03-1.19; TT vs CC: OR=1.24, 95%CI=1.09-1.41; TC vsCC: OR=1.11, 95%CI=1.03-1.20 and TT+TC vs CC: OR=1.09, 95%CI=1.03-1.15) (Hou et al., 2012) . A more recent meta-analysis of 20 studies was published in 2013 that evaluated the association between MTHFR C677CT polymorphism and lung cancer risk (8 Caucasians and 12 Asians) (Liu et al., 2013) . Seven studies suggested that MTHFR C677T polymorphism was associated with an increased lung cancer risk. After stratification by ethnicity (Asian and Caucasian), a significant association between MTHFR C677T polymorphism and lung cancer risk was observed in Asian subjects (OR=1.31, 95% CI =1.01-1.71, p=0.045, TT vs CC), while no significant association was found among Caucasians (OR=1.16; 95% CI =0.91-1.49,p=0.224, TT vs CC) (Liu et al., 2013) . The association between lung cancer and MTHFR C677T polymorphism has been recently confirmed (Rai, 2014) .
In our study, none of the 677 genotypes or allele types was distributed differentially between cases and controls. The lack of association persisted even after stratification by gender or smoking status (Table 2 and 3) . Logistic regression (data not presented) confirmed the lack of association.
The discrepancies in the results may be explained by differences in ethnicity (Cheng et al., 2012) , dietary intake, exposure to environmental carcinogens and sample size. Folate intake has been suggested to modulate cancer risk associated with MTHFR genetic polymorphism (Chen et al., 1996; Ma et al., 1997) . Kiyohora et al have proposed that excessive folate supplementation increases folic acid levels, reduce homocysteine levels and then restore normal methionine levels, particularly in these individuals with the TT genotype of the MTHFR polymorphism (Paul et al., 2004; Kiyohara et al., 2011) .
MTHFR A1298C polymorphism results in an amino acid substitution of alanine to glutamate at codon 429 of the protein in exon 7 (van der Put et al., 1998; Weisberg et al., 1998) . The enzyme activity in vitro is decreased in homozygous variants (CC) and, to a lesser extent, in heterozygotes compared with those without the variant (van der Put et al., 1998) . Studies of the relationship between A1298C genotype and plasma folate and homocysteine are inconsistent (Weisberg et al., 1998; Friedman et al., 1999; Chango et al., 2000; Lievers et al., 2001; Chen et al., 2002) . Enzyme activity in vitro for compound heterozygotes (i.e., heterozygotes for C677T and for A1298C) is unclear (Lievers et al., 2001) . A less active form of MTHFR leads to lower S-adenosyl-Lmethionine levels and consequently to hypomethylation; this phenomenon would be expected to increase the risk of some cancers (Stern et al., 2000) . It is expected that 1298CC carriers are at higher risk for cancer development.
In our study, we also investigated the frequencies of the MTHFR A1298C genotypes in Jordanian patients with LC and the healthy controls. Contrary to the apparent lack of association between MTHFR C677T and the risk of LC, the MTHFR A1298C polymorphism was found to be significantly related with the risk of LC. There was significant interaction between genetic polymorphism at 1298 and both smoking status and subjects' gender. Carriers of the 1298CC genotype as compared with the AA carriers presented 9.9, 6.7 and 7.3 times higher risk of LC in smokers, men, "men who were smokers", respectively. Because of the unequal distribution of gender and smoking among cases and controls, logistic regression was conducted, and confirmed the association between 1298CC and susceptibility to lung cancer. The interaction between A1298C and smoking maybe explained by the reported decreased circulating folate levels due to low folate intake in smokers (Dastur et al., 1972; Witter et al., 1982) .
The results for the A1298C variant are consistent with some but not all published studies. A case-control study evaluated the role of the MTHFR A1298C polymorphisms in 462 lung cancer cases and 379 controls in a Japanese population. The 1298CC genotype was only associated with increased risk among ever-smokers (aOR= 3.2, 95% CI= 1.2-8; p=0.02) non-smokers (aOR=2.83, 95% CI= 1.02-7.8; p=0.05) and excessive drinkers (aOR=7.24, 95% CI=1.89-27.7, p<0.001) (Kiyohara et al., 2011) . The 1298CC genotype was associated with a significantly increased risk of lung cancer in women in one study (Shi et al., 2005) .
A Turkish study involved 64 lung cancer patients and 61 controls. Lung cancer risk was 1.5 times higher in 1298CC genotype though it was not statistically significant. Numerous other studies worldwide have reported lack of association of MTHFR A1298C polymorphism with the risk of lung carcinoma Mao et al., 2008; Boccia et al., 2009; Liu et al., 2013) The physical distance between the two SNPs is short (1.9 kb), and thus one may expect that LD is evident. There is evidence of linkage disequilibrium between the C677T and the A1298C variants of the MTHFR gene with the possibility that both SNPs may be dependent on each other from the genetic and functional point of view (Chen et al., 2002; Shi et al., 2003 DOI:http://dx.doi.org/10.7314/APJCP.2015.16.8.3101 MTHFR Polymorphisms and Lung Cancer in the Jordanian Population r 2 =0.043; LC: D'=0.25, r 2 =0.045) (Shen et al., 2001 ); African Americans (Controls: D'=1, r 2 =0.03) (Keku et al., 2002) ; and mixed-population Americans (Controls: D'=1, r 2 =0.23) (Curtin et al., 2004) . A study from central Europe involved 2250 lung cancer cases, 811 upper aerodigestive tract cases and 2899 controls reported relatively strong linkage disequilibrium (D'= -0.99, r 2 =0.21) (Hung et al., 2007) . Our results indicated that the two loci showed relatively strong LD among cases and controls ([D'] = [0.56 (controls), 0.84 (LC)]).
The most frequent haplotypes of MTHFR among Caucasians were reported as CA (37%); CC (31%); and TA (32%) (Ogino and Wilson, 2003) . A more recent study on Czek subjects reported CA (33.6%); CC (33.7%); and TA (31.9%) as the most common haplotypes (Pardini et al., 2011) . Current study reports a similar trend, albeit a slightly lower TA distribution (24.7%) and higher TC (5%). Because of rarity of TT/CC (677TT and 1298CC) and TT/AC among Jordanians and worldwide, the TC haplotype should be rare as well (Ogino and Wilson, 2003) . The estimated TC haplotype among Caucasians-general populations was reported in less than 1% of the general public (0.3-0.8%) (Ogino and Wilson, 2003; Pardini et al., 2011) . Some studies lacked the TC haplotype (Meisel et al., 2001; Terrazzino et al., 2006) . Still, there may be an increased frequency of the very rare TC haplotype in some parts of the United Kingdom, Canada (Ogino and Wilson, 2003) and USA (Shen et al., 2001) . Utilizing published data, we calculated the TC haplotype among other ethnicities and found it rare as well (non-Hispanic white Americans 13.2% (Shen et al., 2001 );Chinese 9.4 % (Li et al., 2011) and African Americans 0% (Keku et al., 2002) ). Interestingly, the haplotype analysis based on the two investigated MTHFR polymorphisms (C677T and A1298C) showed that haplotype CC was more common in Jordanians with lung cancer than controls (OR=1.6, 95% CI= 1.03-2.4, p=0.037). Examining the literature revealed few studies that investigated the effect of MTHFR haplotypes on susceptibility to lung cancer (Shen et al., 2005; Hung et al., 2007) . The TA haplotype, rather than the CC haplotype, was associated with in increased risk of lung cancer in a Central European study (OR=1.16, 95% CI=1.04-1.29) (Hung et al., 2007) and a Chinese study (OR= 1.67, 95% CI: 1.10-2.52) (Shen et al., 2005) . In the Chinese study the CC haplotype was associated with increased risk though not statistically significant.
In conclusion, the findings of the current study suggest that genetic polymorphism of MTHFR at A1298C and its haplotype analysis at 677and 1298 modulates the risk of LC in the Jordanian population. To our knowledge, this is being reported for the first time among this population.
